Australia markets close in 5 hours 11 minutes
  • ALL ORDS

    7,727.20
    -30.80 (-0.40%)
     
  • ASX 200

    7,420.20
    -28.50 (-0.38%)
     
  • AUD/USD

    0.7503
    -0.0015 (-0.20%)
     
  • OIL

    82.18
    -0.48 (-0.58%)
     
  • GOLD

    1,797.50
    -1.30 (-0.07%)
     
  • BTC-AUD

    77,961.48
    -3,015.15 (-3.72%)
     
  • CMC Crypto 200

    1,397.08
    -77.25 (-5.24%)
     
  • AUD/EUR

    0.6467
    -0.0008 (-0.12%)
     
  • AUD/NZD

    1.0469
    -0.0010 (-0.10%)
     
  • NZX 50

    12,971.14
    -49.12 (-0.38%)
     
  • NASDAQ

    15,598.39
    +38.91 (+0.25%)
     
  • FTSE

    7,253.27
    -24.35 (-0.33%)
     
  • Dow Jones

    35,490.69
    -266.19 (-0.74%)
     
  • DAX

    15,705.81
    -51.25 (-0.33%)
     
  • Hang Seng

    25,628.74
    -409.53 (-1.57%)
     
  • NIKKEI 225

    29,098.24
    -7.77 (-0.03%)
     

Saving the World

COVID-19 changed everything. It not only threatened our individual health and well being, but shook industries and economies across the globe. But the same could be said about the COVID-19 vaccines. Hear from BioNTech cofounder and CEO Ugur Sahin on the process of rapidly developing the world’s most sought after vaccine, alongside Pfizer, and the long-term potential of mRNA-based therapies. Sahin will be joined by Ursheet Parikh of Mayfield Fund to discuss what’s next for startups in this rapidly evolving industry.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting